
Skinomix.ai is a biotechnology company revolutionizing skin analysis through a proprietary technology that combines artificial intelligence and multi-omics science. Leveraging 15 years of fundamental research from INSERM and clinical validation from Montpellier University Hospital, the company offers a multi-omics approach for comprehensive skin analysis. Their patented AI algorithms precisely determine skin biological age by analyzing over 400 biomarkers. This data-driven approach enables tailor-made cosmetic recommendations and innovations. The company is led by a team of internationally renowned experts in research, AI, and business development.

Skinomix.ai is a biotechnology company revolutionizing skin analysis through a proprietary technology that combines artificial intelligence and multi-omics science. Leveraging 15 years of fundamental research from INSERM and clinical validation from Montpellier University Hospital, the company offers a multi-omics approach for comprehensive skin analysis. Their patented AI algorithms precisely determine skin biological age by analyzing over 400 biomarkers. This data-driven approach enables tailor-made cosmetic recommendations and innovations. The company is led by a team of internationally renowned experts in research, AI, and business development.